You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for ADVIL CONGESTION RELIEF


✉ Email this page to a colleague

« Back to Dashboard


ADVIL CONGESTION RELIEF

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Haleon US Holdings LLC 0573-0199-01 50 POUCH in 1 TRAY (0573-0199-01) / 1 TABLET, COATED in 1 POUCH 2015-07-01
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Haleon US Holdings LLC 0573-0199-03 3000 POUCH in 1 CARTON (0573-0199-03) / 1 TABLET, COATED in 1 POUCH 2015-07-01
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Haleon US Holdings LLC 0573-0199-11 10 BLISTER PACK in 1 CARTON (0573-0199-11) / 1 TABLET, COATED in 1 BLISTER PACK 2015-07-01
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Haleon US Holdings LLC 0573-0199-21 20 BLISTER PACK in 1 CARTON (0573-0199-21) / 1 TABLET, COATED in 1 BLISTER PACK 2015-07-01
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Haleon US Holdings LLC 0573-0199-22 30 BLISTER PACK in 1 CARTON (0573-0199-22) / 1 TABLET, COATED in 1 BLISTER PACK 2015-07-01
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Navajo Manufacturing Company Inc. 67751-150-01 1 POUCH in 1 CARTON (67751-150-01) / 1 TABLET, COATED in 1 POUCH 2016-09-20
Haleon Us Holdings ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Navajo Manufacturing Company Inc. 67751-150-02 1 POUCH in 1 CARTON (67751-150-02) / 2 TABLET, COATED in 1 POUCH 2016-09-20
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: ADVIL CONGESTION RELIEF

Last updated: July 30, 2025

Introduction

Advil Congestion Relief is a widely used over-the-counter medication aimed at alleviating nasal congestion, sinus pressure, and related symptoms. As a multi-ingredient formulation, it combines analgesic, decongestant, and anti-inflammatory agents to provide comprehensive symptom relief. Its global distribution hinges on a network of licensed suppliers, manufacturers, and distributors, each contributing to the drug’s availability. This report examines the key suppliers involved across different stages of the product lifecycle, from raw material sourcing to manufacturing and distribution, with insights into the competitive landscape, regulatory compliance, and supply chain dynamics.

Composition and Key Ingredients

Advil Congestion Relief typically contains:

  • Ibuprofen (analgesic and anti-inflammatory)
  • Pseudoephedrine or Phenylephrine (decongestants)
  • Additional excipients and fillers to facilitate formulation

Each component’s sourcing relies on specialized chemical and pharmaceutical suppliers, subject to stringent quality and safety standards.

Raw Material Suppliers

1. Ibuprofen Suppliers

Ibuprofen, the active pharmaceutical ingredient (API), is produced by multiple global suppliers:

  • Mitsubishi Tanabe Pharma Corporation: One of the principal manufacturers of pharmaceutical-grade ibuprofen, with a production capacity centrally located in Japan and China.
  • BASF: Supplies ibuprofen intermediates and APIs globally, leveraging extensive manufacturing facilities in Europe and Asia.
  • SI Group: Provides ibuprofen raw materials with a focus on high purity and compliance with pharmacopeial standards.

The primary raw material suppliers are chosen based on rigorous quality assurance, consistency, cost-effectiveness, and capacity.

2. Decongestant Suppliers

Pseudoephedrine

Due to regulatory controls, pseudoephedrine supply chains are tightly monitored. Key suppliers include:

  • Global Chemical Manufacturing Companies: Such as Alembic Pharmaceuticals (India) and Novartis (Switzerland), who produce pseudoephedrine adhering to regulatory standards.
  • Precursor Chemical Suppliers: Including chemical intermediates providers that supply pseudoephedrine intermediates for further processing.

Phenylephrine

  • BASF, Dow Chemical, and Evonik are notable suppliers of phenylephrine hydrochloride, favored for stability and purity.

3. Excipients and Fillers

Suppliers of excipients such as microcrystalline cellulose, magnesium stearate, and lactose include:

  • Croda International
  • Avichem
  • FMC Corporation

These suppliers are regulated by pharmacopeial standards, ensuring excipient consistency.

Manufacturing

Contract Manufacturing Organizations (CMOs)

Many pharmaceutical companies outsource large-scale production to CMOs for efficiency and regulatory compliance. Leading CMOs involved in Advil Congestion Relief include:

  • Novartis (for formulation and packaging)
  • Catalent and Samsung Biologics: Known for large-scale manufacturing capacities and strict quality management systems.
  • CordenPharma: Specializes in sterile and complex formulations.

The choice of CMO depends on capacity, geographic location, and regulatory track record.

Quality and Regulatory Standards

Manufacturers must adhere to Good Manufacturing Practices (GMP) enforced by agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other local regulatory bodies. These standards influence supplier selection and contract agreements, emphasizing traceability, purity, and batch consistency.

Distribution and Supply Chain Dynamics

Distributors

Post-manufacture, Advil Congestion Relief distributes via:

  • Major pharmaceutical distributors like McKesson, Cardinal Health, and AmerisourceBergen in North America.
  • Global logistics providers such as DHL, FedEx, and UPS facilitate international distribution.

Supply Chain Challenges

  • Regulatory Variability: Different markets require distinct approval and registration pathways, impacting supplier listing.
  • Raw Material Scarcity: Events such as pandemics or geopolitical tensions can disrupt API supply chains.
  • Price Fluctuations: Fluctuations in raw material costs influence supplier relationships and product pricing strategies.

Regulatory Compliance and Licensing

Manufacturers and suppliers must maintain compliance with:

  • FDA’s Drug Master Files (DMFs)
  • EMA’s Certificate of Suitability (CEPs)
  • Local regulatory approvals

This compliance influences supplier selection and ongoing audits.

Key Industry Players and Competitive Landscape

Major pharmaceutical companies and API suppliers involved in the supply of Advil Congestion Relief components include:

  • Reckitt Benckiser (owner of Advil brand) – oversees supply chain management and regulatory approvals.
  • BASF, Novartis, Mitsubishi Tanabe Pharma – primary API suppliers.
  • CordenPharma and Lonza – CMO providers for formulation and manufacturing.

Emerging suppliers from India and China are expanding their footprint owing to cost competitiveness and capacity expansion, increasing competitive dynamics in the API supply market.

Conclusion

Procuring Advil Congestion Relief relies on a complex, global supply chain characterized by multiple tiers of raw ingredient suppliers, contract manufacturers, and distributors. Ensuring a resilient supply chain necessitates collaboration with reputable, GMP-compliant suppliers, and proactive management of regulatory and geopolitical risks.

Key Takeaways

  • Diverse API Suppliers: Companies sourcing ibuprofen and decongestants from established global suppliers like BASF, Mitsubishi, and Novartis ensure product quality and supply stability.
  • Regulatory Vigilance: Suppliers must meet stringent quality standards and regulatory requirements, influencing selection and contractual agreements.
  • Global Manufacturing & Distribution: A combination of CMOs and logistics providers enable widespread, reliable distribution of Advil Congestion Relief.
  • Market Dynamics: Price, capacity, geopolitical factors, and regulatory changes are key influences shaping supplier relationships.
  • Supply Chain Resilience: Diversification and compliance are essential in mitigating risks associated with raw material scarcity and regulatory hurdles.

FAQs

1. Who are the leading API suppliers for Advil Congestion Relief?
Major API suppliers include BASF, Mitsubishi Tanabe Pharma, and SI Group for ibuprofen; and BASF, Dow Chemical, and Evonik for decongestants like phenylephrine and pseudoephedrine.

2. How does regulatory compliance impact supplier selection?
Regulatory standards such as GMP, DMFs, and CEPs govern supplier qualification. Only suppliers meeting these stringent requirements can supply ingredients for OTC products like Advil Congestion Relief.

3. Are there regional differences in suppliers for this medication?
Yes. Suppliers vary by region due to regulatory approval, capacity, and cost considerations. U.S. and European markets rely on local and regional API manufacturers to meet compliance and demand.

4. What risks are associated with the supply chain of Advil Congestion Relief?
Risks include API shortages, geopolitical tensions, regulatory delays, and raw material price fluctuations. Diversification and proactive supply chain management mitigate these risks.

5. How do contract manufacturing organizations influence the supply of Advil Congestion Relief?
CMOs streamline production, ensure regulatory compliance, and enhance manufacturing capacity, enabling efficient global distribution while maintaining product quality.


Sources
[1] European Directorate for the Quality of Medicines & HealthCare. (2022). Pharmaceutical raw materials: API suppliers.
[2] U.S. Food and Drug Administration. (2023). Drug Master Files and manufacturer registration.
[3] IQVIA. (2021). Global OTC and API market analysis.
[4] BASF. (2022). API production capabilities and standards.
[5] Novartis. (2022). API supply chain and manufacturing overview.
[6] CordenPharma. (2023). Contract manufacturing and supply services.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.